SXT and Taxo A disks for presumptive identification of group A and B streptococci in throat cultures.
A bacitracin (0.04 units, BBL)-SXT (trimethoprim, 1.25 mg, plus sulfamethoxazole, 23.75 mg, BBL) susceptibility test was 94% accurate in presumptively identifying streptococci as either group A, B or not group A and B.
D001414:Bacitracin / Q000494:pharmacology; D006801:Humans; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000379:methods*; D010614:Pharynx / Q000382:microbiology*; D013420:Sulfamethoxazole / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D001414:Bacitracin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D008712:Methicillin